P2578
Kikuchi diseasegranulomatosis with polyangiitisgraft-versus-host diseaseErdheim-Chester diseasetwin-to-twin transfusion syndromecryptococcosislymphangitisChylous ascitesRetroperitoneal fibrosismixed connective tissue diseaseautoimmune enteropathyT-cell prolymphocytic leukemiapolymyalgia rheumaticaautoimmune disease of skin and connective tissueimmune system organ benign neoplasmcongenital toxoplasmosisbasophil adenomabasophilic carcinomaeye lymphomarelapsing polychondritismicrosporidiosisGuillain–Barré SyndromeMast cell activation syndromeKawasaki diseaseautoinflammatory diseaseotulipeniaChronic recurrent multifocal osteomyelitisprimary immunodeficiency diseasecytokine release syndromeImmune-mediated diseaselymph node tuberculosisnatural killer cell leukemiaautoimmune hypophysitisB-cell lymphomacatastrophic antiphospholipid syndromeimmune reconstitution inflammatory syndromeautoimmune glomerulonephritisautoimmune cardiomyopathyautoimmune vasculitisHirata disease
P279
Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human diseaseApproaches to detecting immunotoxic effects of environmental contaminants in humansThe role of neutrophils in immune dysfunction during severe inflammationThe Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their TherapyExpression Quantitative Trait Loci Information Improves Predictive Modeling of Disease Relevance of Non-Coding Genetic VariationPathophysiology and Immune Dysfunction in EndometriosisIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesMultiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationshipHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansNeuroimmune mechanisms in Krabbe's diseaseThe role of macrophage polarization in infectious and inflammatory diseasesAffective immunology: where emotions and the immune response converge.Clinical trials for stem cell therapiesBreaking patterns of environmentally influenced disease for health risk reduction: immune perspectivesA review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.Transcriptional and epigenetic regulation of T-helper lineage specification.Therapeutic Effects of Bee Venom on Immunological and Neurological DiseasesGWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseasesMicroRNAs in common human diseases.Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationEndogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.Parasitic helminths: new weapons against immunological disorders.Innate immunity: ignored for decades, but not forgotten.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity.Are mesenchymal stromal cells immune cells?Immunogenomic approaches to understand the function of immune disease variants.Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response.Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?Epigenomic Modifications Mediating Antibody Maturation.The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease.Cytokine release syndrome.Selenium, Selenoproteins, and ImmunityInflammasomes in Tissue Damages and Immune Disorders After TraumaAspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and CancerBe on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated DiseasesUnique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implicationsThe Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases
P921
Q1060827-EADFD39A-88B1-4844-BE57-DE918D91D2DEQ1161568-C5FC84DC-F964-4CCA-A1C0-590B341C11B5Q1194520-47255295-79AD-4092-9CC0-08F6E4843CADQ1349259-6DCE5C15-F4A5-4781-890E-928B6708FEC7Q1409160-F32CB04F-876E-4FAD-AFE3-48D2A415AE28Q1470140-65690CC9-80C5-4436-B4DD-B7B2AEB36FC6Q1476027-CDA32277-B739-49F1-8305-A2921A6B74E4Q15727012-FF1624E0-E8BA-43EB-857F-4D4A1DFC44B0Q1600050-093D1C14-F888-4F72-BE00-EBD6526B097BQ1622407-B72E45B0-CD69-4AC3-8D94-136ACBEE6546Q17130915-67000DAF-A3B6-42B6-A70B-9C6E04A2FEBAQ17152512-D4CBF19C-7658-490B-8D9C-1DF88966498EQ1752891-0B840F41-C196-4FA5-AC7A-DB5BB6E0E91DQ18553613-38E392B1-26F2-4D49-B222-78FD275FB1E5Q18553653-e2b798ad-48f2-0050-eddd-4bde2ab0325dQ18554492-1FA1630C-B290-4C8C-937E-9060966869F5Q18556374-4417D659-FBBF-429B-B540-AD18DC416CE1Q18556543-CA32D24A-8D5D-495F-806E-9CF0A1A4175EQ18557401-9683EB77-74EE-4E8C-AD75-168513876A90Q187656-21BECA5D-6FD0-42E4-BF3D-845C934709FFQ1934052-0AAC42FB-CE64-4393-B6D7-9B7EF6572257Q205214-3B9FB4CC-DF0E-40E2-B743-25095A24969DQ24238949-7b07229b-4423-f015-56b3-e39ffb196b8aQ265936-4908ECBD-786F-4619-9F60-0B3A005660DEQ26882919-29f17250-4642-60a6-b3a2-5a42f0439feeQ27164424-A4CC9589-7401-4030-8362-76400DD260B1Q2787011-8F841445-3F32-450B-998D-E18C5DD04B8EQ3043160-375E2248-EB88-4939-BFD1-F1EF5DC42138Q3961647-1da37445-4137-3b47-ff9a-0ee60961a0f5Q4117969-de94dacc-47c4-4ae4-760d-e79d05a1b593Q4678337-8A0E519C-B65F-4995-8E8D-E50AC3DC6D5DQ4692280-89821905-ABE0-470F-BD02-B902E3C1006DQ4826342-E4B093E7-0C0B-4338-A197-CCF0632BC3FAQ4833719-06B2DE00-EFA8-4084-8FAD-AFFAAE76DA1FQ5051580-4BB838CF-A234-41AB-9EDF-9B5C78F00DBCQ539986-d01d5095-485d-e116-e1dd-16261365b08fQ55009191-FCAD9CE7-86ED-45A7-B1EE-4754C6ED3334Q55009192-C36991A1-8B12-4EED-82BB-791688B2BF9BQ55009195-E0E07052-43D3-4FBD-A50A-7F6FE75D971EQ55009198-DC4433E5-0E87-42F4-BB0F-52692016D075
P279
description
Krankheit
@de
ampio gruppo di complessi sind ...... ionale del sistema immunitario
@it
enfermedad del sistema inmunológico
@es
maladie affectant le système immunitaire
@fr
name
Gangguan imun
@ms
Immune disorder
@en
doença do sistema imunológico
@pt
enfermedad inmunológica
@es
gaixotasun immunologiko
@eu
immunologisk sjukdom
@nn
immunologisk sykdom
@nb
immunsjukdom
@sv
immunsystemssygdom
@da
imuna malsano
@eo
type
label
Gangguan imun
@ms
Immune disorder
@en
doença do sistema imunológico
@pt
enfermedad inmunológica
@es
gaixotasun immunologiko
@eu
immunologisk sjukdom
@nn
immunologisk sykdom
@nb
immunsjukdom
@sv
immunsystemssygdom
@da
imuna malsano
@eo
altLabel
desorden inmunologico
@es
desorden inmunológico
@es
enfermedad del sistema inmune
@es
enfermedad del sistema inmunologico
@es
enfermedad del sistema inmunológico
@es
enfermedad inmunologica
@es
enfermedades del sistema inmune
@es
eritasun immunologiko
@eu
immunitate-sistemako eritasun
@eu
immunitate-sistemako gaixotasun
@eu
prefLabel
Gangguan imun
@ms
Immune disorder
@en
doença do sistema imunológico
@pt
enfermedad inmunológica
@es
gaixotasun immunologiko
@eu
immunologisk sjukdom
@nn
immunologisk sykdom
@nb
immunsjukdom
@sv
immunsystemssygdom
@da
imuna malsano
@eo
P2888
P486
P6366
P672
P7033
P1417
science/immune-system-disorder
P1550
P1748
P1995
P2579
P2892
P31
P3219
immunopathies
P373
Diseases and disorders of the immune system
P3827
immune-system-diseases
P4229
P486
P5270
MONDO:0020008
P6366
2780732581